-
The Safety of 5-AMINO-3-CHLOROPYRIDAZINE
Time of Update: 2023-05-14
In addition to these personal protective measures, it is also important for employers to implement appropriate safety protocols and procedures to minimize the risk of exposure to 5-amino-3-chloropyridazine.
-
The Safety of N-[(1,1-Dimethylethoxy)carbonyl]-N-methylglycine [2-(methylamino)-3-pyridinyl]methyl ester
Time of Update: 2023-05-12
The safety of N-[(1,1-Dimethylethoxy)carbonyl]-N-methylglycine [2-(methylamino)-3-pyridinyl]methyl ester, also known as 2-MPE, is a crucial concern in the chemical industry, as it is a potentially hazardous substance that can pose a risk to workers and the environment if not handled properly.
-
The Safety of 4-CHLORO-N,N-DIMETHYL-PYRIDINE-2-CARBOXAMIDE
Time of Update: 2023-05-05
The handling and use of DCMU in the chemical industry requires strict safety protocols to be in place to protect workers from the potential health hazards associated with the chemical.
-
The Safety of 3-Pyridinecarboxaldehyde, 4-bromo-, hydrobromide (1:1
Time of Update: 2023-05-05
In addition to its potential cancer-causing effects, this compound is also associated with a range of other health hazards, including skin irritation, respiratory problems, and neurological effects.
-
Nature Biotechnology announces important advances in CRISPR technology: removing the binding sites of oncogenes can slow down the growth of cancer cells
Time of Update: 2022-09-30
essayA competitive precision CRISPR method to identify the fitness effects of transcription factor binding sites The researchers discovered a mechanism by which a common oncogene activated by cancer patients affects how fast cells grow.
-
FDA approves Bristol-Myers Squibb's Opdivo, the first NSCLC neoadjuvant therapy
Time of Update: 2022-05-20
The study data showed that the addition of Opdivo to chemotherapy in patients with stage 1b to 3a NSCLC significantly improved EFS compared to chemotherapy alone, reducing the risk of progression, recurrence or death by 37% .
-
JCEM: Obesity and Breast Cancer Risk
Time of Update: 2022-05-12
immunization with metforminThe researchers synthesized the data and found that increased body mass index and weight gain were associated with an increased risk of hormone receptor-positive breast cancer after menopause .
-
The sea of stars, set sail - the 2022 edition of the "CSCO Prostate Cancer Diagnosis and Treatment Guidelines" update officially launched
Time of Update: 2022-05-02
*Only for medical professionals to read and refer to the 2022 edition of the "CSCO Prostate Cancer Diagnosis and Treatment Guidelines" update work officially kicked off! Let us look forward to the ne
-
Nobel Laureate Reveals Cause of Indirect Carcinogenicity of Milk/Beef
Time of Update: 2022-02-21
The team discovered the presence of BMMF in cells adjacent to tumors in colon cancer patients, and further discovered that BMMF triggers local chronic inflammation, leading to elevated levels of reactive oxygen species (ROS) .
-
Nature: Significant progress
Time of Update: 2022-01-08
In other words, based on our research results, people would think that a diet low in palmitic acid Can effectively slow down the metastasis process, but to determine this requires more research work .
-
Express treatment of specific lung cancer patients, Hutchison Medicine and AstraZeneca initiate phase 3 clinical trials of combination therapy in China
Time of Update: 2021-12-05
The trial will be carried out in lung cancer patients with EGFR and MET mutations or abnormalities who have relapsed after receiving EGFR inhibitor treatment, and aims to evaluate highly selective and potent oral mesenchymal transition factor (MET) tyrosine kinase inhibitors (TKI) Orpathys, the efficacy and safety of the combination with AstraZeneca’s third-generation irreversible epidermal growth factor receptor (EGFR) TKI Tagrisso .
-
J Immunother Cancer: The correlation between body mass index, dosing strategy and the efficacy of immune checkpoint inhibitors
Time of Update: 2021-06-28
Body mass index (BMI) and a plurality of types of cancer to increase immune reaction checkpoint inhibitor (ICI) relating to improved immunizationResearchers extracted clinical data of cancer patients treated with ICI, including age, gender, cancer type, BMI, ICI type, drug delivery strategy (based on weight or fixation), imaging response, overall survival (OS), and progression-free Lifetime (PFS) .
-
The use of anti-inflammatory drugs in surgery can improve the prognostication of cancer patients
Time of Update: 2021-02-06
The results of the world's first clinical study (SURGUVANT) to assess the improvement in the effectiveness of surgical treatment using anti-inflammatory drugs during surgery in colon cancer patients are published in BMC Cancer.
-
Br J Cancer: TNIK inhibitor NCB-0846 blocks the TGF beta/SMAD signaling path path to inhibit the metastasis of lung cancer
Time of Update: 2020-12-16
study explores the effects of NCB-0846 on the EMT process of lung cancer induced by TGF beta1.
NCB-0846 inhibits the metastasis of lung cancer cells Researchers have found that NCB-0846 inhibits the EMT process of TGF beta-induced A549 cells.
-
Br J Cancer: Nitoju monoantigen anti-combined cisplatin radiotherapy improves prognostication in patients with local advanced head and neck squamous cancer expressed by high HIF1 alpha
Time of Update: 2020-10-03
the study was designed to analyze the effects and prognostic effects of associated biomarkers in PATIENTs with HPV-negative LA-HNSCC (local late-stage head and neck squamous cell carcinoma).
, the study confirmed that the high expression level of HIF1 alpha indicates that HPV-negative LA-HNSCC patients are less effective at CRT treatment.
